• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康受试者中药物剂型胃肠道转运的差异。

Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.

作者信息

Coupe A J, Davis S S, Wilding I R

机构信息

Department of Pharmaceutical Sciences, University of Nottingham, U.K.

出版信息

Pharm Res. 1991 Mar;8(3):360-4. doi: 10.1023/a:1015849700421.

DOI:10.1023/a:1015849700421
PMID:2052525
Abstract

The variability in the gastrointestinal transit of a multiple-unit and single-unit dosage form was investigated following a light breakfast in six, healthy, male volunteers after repeated weekly administration. The dosage forms were labeled with gamma-emitting radionuclides and the transit of the formulations was monitored on 4 separate study days using the technique of dual-isotope gamma scintigraphy. Gastric emptying times and small intestinal transit times were calculated and compared statistically within and between subjects using the standard deviation and coefficient of variance. The variability in gastric emptying of single- and multiple-unit systems was large; the intrasubject variation being less than the intersubject. There was less variation in small intestinal transit times for the single- and multiple-unit formulations than in gastric emptying, intrasubject variation again being less than intersubject variation.

摘要

在六名健康男性志愿者每周重复给药后,于清淡早餐后研究了多单元和单单元剂型在胃肠道转运中的变异性。剂型用发射γ射线的放射性核素标记,并在4个独立的研究日使用双同位素γ闪烁扫描技术监测制剂的转运。计算胃排空时间和小肠转运时间,并使用标准差和变异系数在受试者内和受试者间进行统计学比较。单单元和多单元系统的胃排空变异性很大;受试者内变异小于受试者间变异。单单元和多单元制剂的小肠转运时间变异小于胃排空变异,受试者内变异同样小于受试者间变异。

相似文献

1
Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.健康受试者中药物剂型胃肠道转运的差异。
Pharm Res. 1991 Mar;8(3):360-4. doi: 10.1023/a:1015849700421.
2
Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.模型微型片剂控释口服剂型在空腹人类志愿者体内的胃肠道转运。
J Pharm Pharmacol. 2007 Jul;59(7):941-5. doi: 10.1211/jpp.59.7.0005.
3
Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.采用体内-体外-体内模拟方法理解肠溶片剂的体内性能:案例分析双氯芬酸。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1337-47. doi: 10.1016/j.ejpb.2013.09.009. Epub 2013 Sep 18.
4
Transit of pharmaceutical dosage forms through the small intestine.药物剂型在小肠中的转运。
Gut. 1986 Aug;27(8):886-92. doi: 10.1136/gut.27.8.886.
5
Characterization of colonic transit of nondisintegrating tablets in healthy subjects.健康受试者中不崩解片剂的结肠转运特征
Dig Dis Sci. 1993 Jun;38(6):1015-21. doi: 10.1007/BF01295715.
6
Effects of Diurnal Variation and Food on Gastrointestinal Transit of In-Labeled Hydrogel Matrix Extended-Release Tablets and Tc-Labeled Pellets in Humans.人体标记水凝胶基质控释片和 Tc 标记微丸的胃肠道转运的昼夜变化和食物影响。
J Pharm Sci. 2020 Feb;109(2):1020-1025. doi: 10.1016/j.xphs.2019.09.025. Epub 2019 Oct 7.
7
Correlation of phenylpropanolamine bioavailability with gastrointestinal transit by scintigraphic monitoring of 111In-labeled hydroxypropylmethylcellulose matrices.
Pharm Res. 1989 Apr;6(4):274-8. doi: 10.1023/a:1015986121822.
8
Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.采用一种新的 MRI 标记技术对漂浮和下沉型抗酸胶囊的胃肠道转运和崩解行为进行表征。
Eur J Pharm Sci. 2019 Mar 1;129:163-172. doi: 10.1016/j.ejps.2019.01.012. Epub 2019 Jan 10.
9
Gastrointestinal transit of dosage forms in the pig.
J Pharm Pharmacol. 2001 Jan;53(1):33-9. doi: 10.1211/0022357011775163.
10
Meal-induced acceleration of tablet transit through the human small intestine.进餐引起的片剂在人体小肠内转运加速。
Pharm Res. 2009 Feb;26(2):356-60. doi: 10.1007/s11095-008-9749-2. Epub 2008 Nov 4.

引用本文的文献

1
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.构建一种蛋白酶稳定的口服单域抗体以抑制白细胞介素-23信号传导。
Proc Natl Acad Sci U S A. 2025 Jun 3;122(22):e2501635122. doi: 10.1073/pnas.2501635122. Epub 2025 May 28.
2
Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling.弱酸性药物体外生物药剂学数据的机理建模:为基于生理的生物药剂学建模推导基本参数的途径。
AAPS J. 2024 Apr 4;26(3):44. doi: 10.1208/s12248-024-00912-y.
3
A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles.

本文引用的文献

1
The effect of density on the gastric emptying of single- and multiple-unit dosage forms.密度对单剂量和多剂量剂型胃排空的影响。
Pharm Res. 1986 Aug;3(4):208-13. doi: 10.1023/A:1016334629169.
2
Effect of stress on the gastric emptying of capsules.
J Clin Hosp Pharm. 1984 Sep;9(3):249-51. doi: 10.1111/j.1365-2710.1984.tb01083.x.
3
Effect of exercise on gastric emptying and gastric secretion.运动对胃排空及胃液分泌的影响。
Digestion. 1974;10(1):1-8. doi: 10.1159/000197517.
脂质纳米粒增强经口递药的窗口。
Drug Des Devel Ther. 2024 Feb 29;18:613-630. doi: 10.2147/DDDT.S439975. eCollection 2024.
4
Thiolated Cellulose: A Dual-Acting Mucoadhesive and Permeation-Enhancing Polymer.巯基化纤维素:一种具有双重作用的黏附性和渗透增强聚合物。
Biomacromolecules. 2023 Nov 13;24(11):4880-4889. doi: 10.1021/acs.biomac.3c00577. Epub 2023 Oct 5.
5
Microfluidic-Assisted Production of Gastro-Resistant Active-Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells.微流控辅助生产抗胃活性靶向硅藻土纳米颗粒用于转移性结直肠癌细胞中海仑胶的局部释放
Adv Healthc Mater. 2023 Jan;12(6):e2202672. doi: 10.1002/adhm.202202672. Epub 2022 Dec 11.
6
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.壳聚糖纳米粒在基于口服的结直肠癌治疗药物递送中的最新进展。
Int J Nanomedicine. 2022 Sep 7;17:3933-3966. doi: 10.2147/IJN.S375229. eCollection 2022.
7
Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space - Part I: Adults.用于司美替尼食物效应研究和胶囊溶出安全空间的基于生理的生物药剂学模型 - 第一部分:成人
Pharm Res. 2023 Feb;40(2):387-403. doi: 10.1007/s11095-022-03339-2. Epub 2022 Aug 24.
8
Impact of gastric and bowel surgery on gastrointestinal drug delivery.胃和肠手术对胃肠道药物输送的影响。
Drug Deliv Transl Res. 2023 Jan;13(1):37-53. doi: 10.1007/s13346-022-01179-6. Epub 2022 May 18.
9
Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed-Release and Extended-Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations.结肠吸收对迟释和缓释哌甲酯药代动力学特性的影响:体内、体外和模型评估。
Clin Pharmacol Drug Dev. 2022 Aug;11(8):966-975. doi: 10.1002/cpdd.1089. Epub 2022 Mar 22.
10
pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of .用于生物控制的pH依赖性分子门介孔微粒
Pharmaceutics. 2021 Jan 13;13(1):94. doi: 10.3390/pharmaceutics13010094.
4
Influence of food and marker length on gastric emptying of indigestible radiopaque markers in healthy humans.食物和标志物长度对健康人胃内难消化不透X线标志物排空的影响。
Gastroenterology. 1986 Dec;91(6):1452-5. doi: 10.1016/0016-5085(86)90200-3.
5
Transit of pharmaceutical dosage forms through the small intestine.药物剂型在小肠中的转运。
Gut. 1986 Aug;27(8):886-92. doi: 10.1136/gut.27.8.886.
6
Variability of gastric emptying measurements in man employing standardized radiolabeled meals.使用标准化放射性标记餐对人体胃排空测量的变异性。
Dig Dis Sci. 1986 Aug;31(8):799-806. doi: 10.1007/BF01296046.
7
Exercise and small intestinal transit.
Nucl Med Commun. 1987 Feb;8(2):105-10. doi: 10.1097/00006231-198702000-00009.
8
Gastric emptying of large single unit dosage forms.大的单一单位剂型的胃排空
J Pharm Pharmacol. 1988 Mar;40(3):205-7. doi: 10.1111/j.2042-7158.1988.tb05220.x.
9
The effect of polycarbophil on the gastric emptying of pellets.
J Pharm Pharmacol. 1987 Jan;39(1):47-9. doi: 10.1111/j.2042-7158.1987.tb07161.x.
10
The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations.
J Pharm Pharmacol. 1985 Feb;37(2):91-5. doi: 10.1111/j.2042-7158.1985.tb05013.x.